Literature DB >> 1192428

The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

P Janik, P Briand, N R Hartmann.   

Abstract

Hormone-dependent mammary tumors were induced in virgin GR mice by treatment with estrone and progesterone. Discontinuation of hormonal treatment was followed by regression of the tumor. This response to hormone treatment was also observed in the first transplant generation in inbred syngeneic hosts, but after several transplantations the tumor growth became hormone independent. The hormone dependence of the primary tumors and tumors after a single transplantation was demonstrated by growth curves. Furthermore, the cell proliferation kinetics has been investigated in a growing as well as in a regressing hormone-dependent tumor after a single transplantation from the same primary tumor. The experimental data consist of growth curves, percentage-labeled mitoses curves, and labeling indices. Since these data do not contain information concerning the localization of the cell loss in the cell cycle, they were analyzed by a computer method based on three mathematical models differing in respect to the mode of cell loss. All three models gave approximately the same estimates of the cell kinetic parameters in the growing as well as the regressing tumor. The results for the growing, hormone-dependent tumor showed a growth fraction of 62%, a cell production rate of 3.4%/hr, and a cell loss rate of 2.3%/hr. Regression of the tumor after hormonal deprivation was accompanied by a decrease in growth fraction to 18% and a decrease in the cell production rate to 0.9%/hr, while the cell loss rate was unchanged at 2.8%/hr. Furthermore, the discontinuation of hormonal treatment introduced an increase in the mean transit time of the cell cycle, particularly in the mean transit time of the G1 phase. The results might indicate that estrone and progesterone treatment stimulated growth of hormone-dependent GR mouse mammary tumors mainly by an increase of growth fraction and cell production rate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192428

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

1.  Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.

Authors:  S J Hall; T C Thompson
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.

Authors:  M Landström; J E Damber; A Bergh; R Tomic
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  CUDC-101, a Novel Inhibitor of Full-Length Androgen Receptor (flAR) and Androgen Receptor Variant 7 (AR-V7) Activity: Mechanism of Action and In Vivo Efficacy.

Authors:  Huiying Sun; Sanjay N Mediwala; Adam T Szafran; Michael A Mancini; Marco Marcelli
Journal:  Horm Cancer       Date:  2016-03-08       Impact factor: 3.869

4.  The in vivo cytostatic effect induced by Propionibacterium granulosum on murine tumor cells.

Authors:  P Janik; W Roszkowski; H L Ko; S Szmigielski; G Pulverer; J Jeljaszewicz
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.

Authors:  Anat Globerson-Levin; Tova Waks; Zelig Eshhar
Journal:  Mol Ther       Date:  2014-02-27       Impact factor: 11.454

6.  The rat bladder tumor model system RBT resembles phenotypically and cytogenetically human superficial transitional cell carcinoma.

Authors:  R J van Moorselaar; T Ichikawa; H E Schaafsma; P H Jap; J T Isaacs; P van Stratum; F C Ramaekers; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1993

7.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.

Authors:  J L Camps; S M Chang; T C Hsu; M R Freeman; S J Hong; H E Zhau; A C von Eschenbach; L W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.

Authors:  Johanna Tuomela; Maija Valta; Jani Seppänen; Kati Tarkkonen; H Kalervo Väänänen; Pirkko Härkönen
Journal:  BMC Cancer       Date:  2009-10-12       Impact factor: 4.430

9.  Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.

Authors:  D Alwyn Dart; Bradley Spencer-Dene; Simon C Gamble; Jonathan Waxman; Charlotte L Bevan
Journal:  Endocr Relat Cancer       Date:  2009-07-27       Impact factor: 5.678

10.  The Sonic Hedgehog pathway stimulates prostate tumor growth by paracrine signaling and recapitulates embryonic gene expression in tumor myofibroblasts.

Authors:  A Shaw; J Gipp; W Bushman
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.